Cargando…
Betulinic Acid for Cancer Treatment and Prevention
Betulinic acid is a natural product with a range of biological effects, for example potent antitumor activity. This anticancer property is linked to its ability to induce apoptotic cell death in cancer cells by triggering the mitochondrial pathway of apoptosis. In contrast to the cytotoxicity of bet...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2658785/ https://www.ncbi.nlm.nih.gov/pubmed/19325847 http://dx.doi.org/10.3390/ijms9061096 |
_version_ | 1782165653052981248 |
---|---|
author | Fulda, Simone |
author_facet | Fulda, Simone |
author_sort | Fulda, Simone |
collection | PubMed |
description | Betulinic acid is a natural product with a range of biological effects, for example potent antitumor activity. This anticancer property is linked to its ability to induce apoptotic cell death in cancer cells by triggering the mitochondrial pathway of apoptosis. In contrast to the cytotoxicity of betulinic acid against a variety of cancer types, normal cells and tissue are relatively resistant to betulinic acid, pointing to a therapeutic window. Compounds that exert a direct action on mitochondria present promising experimental cancer therapeutics, since they may trigger cell death under circumstances in which standard chemotherapeutics fail. Thus, mitochondrion-targeted agents such as betulinic acid hold great promise as a novel therapeutic strategy in the treatment of human cancers. |
format | Text |
id | pubmed-2658785 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Molecular Diversity Preservation International (MDPI) |
record_format | MEDLINE/PubMed |
spelling | pubmed-26587852009-03-25 Betulinic Acid for Cancer Treatment and Prevention Fulda, Simone Int J Mol Sci Review Betulinic acid is a natural product with a range of biological effects, for example potent antitumor activity. This anticancer property is linked to its ability to induce apoptotic cell death in cancer cells by triggering the mitochondrial pathway of apoptosis. In contrast to the cytotoxicity of betulinic acid against a variety of cancer types, normal cells and tissue are relatively resistant to betulinic acid, pointing to a therapeutic window. Compounds that exert a direct action on mitochondria present promising experimental cancer therapeutics, since they may trigger cell death under circumstances in which standard chemotherapeutics fail. Thus, mitochondrion-targeted agents such as betulinic acid hold great promise as a novel therapeutic strategy in the treatment of human cancers. Molecular Diversity Preservation International (MDPI) 2008-06-27 /pmc/articles/PMC2658785/ /pubmed/19325847 http://dx.doi.org/10.3390/ijms9061096 Text en |
spellingShingle | Review Fulda, Simone Betulinic Acid for Cancer Treatment and Prevention |
title | Betulinic Acid for Cancer Treatment and Prevention |
title_full | Betulinic Acid for Cancer Treatment and Prevention |
title_fullStr | Betulinic Acid for Cancer Treatment and Prevention |
title_full_unstemmed | Betulinic Acid for Cancer Treatment and Prevention |
title_short | Betulinic Acid for Cancer Treatment and Prevention |
title_sort | betulinic acid for cancer treatment and prevention |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2658785/ https://www.ncbi.nlm.nih.gov/pubmed/19325847 http://dx.doi.org/10.3390/ijms9061096 |
work_keys_str_mv | AT fuldasimone betulinicacidforcancertreatmentandprevention |